Please read the Ryaltris® Patient Information Leaflet (PIL) carefully. A paper copy comes with the medicine pack and an online version can be found here. If you have any questions, please ask your doctor or pharmacist.
The following information is provided to supplement the PIL; it does not replace the important information you can find there.
Please read the Ryaltris® Patient Information Leaflet (PIL) carefully. A paper copy comes with the medicine pack and an online version can be found here. If you have any questions, please ask your doctor or pharmacist.
The following information is provided to supplement the PIL; it does not replace the important information you can find there.
Ryaltris® is used to treat the symptoms of moderate to severe seasonal allergic rhinitis (also called hayfever) and perennial rhinitis in adults and adolescents 12 years of age or older.1
Ryaltris® relieves the symptoms of allergies, like runny nose, sneezing and itchy or blocked nose.1
Ryaltris® contains two active substances: olopatadine and mometasone furoate.1
Olopatadine is an antihistamine that works by preventing the effects of substances such as histamine (produced by the body as part of an allergic reaction).1
Mometasone furoate is a corticosteroid (or steroid) that works by reducing inflammation that is often found in allergic rhinitis.1
Using Ryaltris® should be simple: the recommended dose in adults and adolescents (12 years and older) is 2 sprays into each nostril, morning and night.1 However, it is important to know how to use it properly to ensure you get the most from your medicine. Always take this medicine exactly as your doctor or pharmacist has told you and check with them if you are unsure. You will also find instructions in the Patient Information Leaflet that comes with every pack.
Click the play icon to view film >After using Ryaltris®, wipe the nozzle carefully with a clean handkerchief or tissue and replace the cap, to avoid the nozzle getting blocked.1
If the nozzle gets blocked, follow these steps:
As with all medicines, keep Ryaltris® out of the sight and reach of children. Ensure you don’t use it after the expiry date shown on the bottle and carton, and use within 2 months of first opening.
Ask your pharmacist how to throw away medicines you no longer use.
Like all medicines, Ryaltris® can cause side effects, although not everybody gets them.
Common side effects (that may affect up to 1 in 10 people) are a bitter taste in your mouth, a nosebleed, and slight irritation of the inside of the nose. If you get any side effects, talk to your doctor or pharmacist. More information on side effects is available in the Patient Information Leaflet.
You are unlikely to have any problems but if you’re worried or if you have used doses higher than recommended over a long period, contact your doctor. If you use steroids for a long time or in large amounts they may rarely affect some of your hormones. In children this may affect growth and development.
Take it as soon as you remember, then take the next dose at the usual time. Do not take a double dose to make up for a forgotten dose.
Tell your doctor or pharmacist about any medicines you are taking, have recently taken or might take. If you are taking other medicines by oral or local route (nasal or eye drops) containing olopatadine or other antihistamines, your doctor may advise you to stop taking them once you begin using Ryaltris®. Some medicines may increase the effects of Ryaltris® and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV: ritonavir, cobicistat).
It can be a challenge to live with allergic rhinitis (including hayfever), but there is support out there to help you.
By clicking this link, you are leaving the Ryaltris® website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page.’